Aurora Cannabis Inc. vs Johnson & Johnson — Stock Comparison
Aurora Cannabis Inc. (ACB) and Johnson & Johnson (JNJ) are both listed on US exchanges. This page compares their Q·Score ratings, key fundamentals (P/E, margins, growth), and Wall Street analyst consensus side by side. Data sourced from Yahoo Finance and updated on each page load.
Johnson & Johnson holds a significant lead over Aurora Cannabis Inc. on Q·Score (7.1 vs 4.4 out of 10), led by Quality (9.3 vs 2.1) and Valuation (7.3 vs 3.8). Aurora Cannabis Inc. scores higher on Health, reflecting stronger balance sheet strength. Analysts covering JNJ have a consensus price target implying +10.7% from current levels.
Price Performance
Normalised to 100 at period start — shows relative performance.
Q·Score Breakdown
Clean balance sheet with low leverage (0.0× debt-to-equity).
⚠ currently unprofitable (-42% margin).
High-quality business with 26% return on equity and 22% profit margins.
⚠ earnings contracting 53% year-over-year.
Analyst Consensus
Fundamentals
Frequently Asked Questions
ACB vs JNJ: which stock scores better overall?
Based on Q·Score, Johnson & Johnson (JNJ) scores 7.1/10 versus Aurora Cannabis Inc. (ACB) at 4.4/10. The Q·Score measures five dimensions: Quality, Health, Growth, Valuation, and Sentiment. For informational purposes only — not financial advice.
Which has better revenue growth: ACB or JNJ?
Johnson & Johnson (JNJ) scores higher on Growth (5.1/10 vs 3.7/10). Aurora Cannabis Inc. reports revenue growth (5.1% YoY) while Johnson & Johnson reports (9.9% YoY). Growth scores reflect revenue and earnings momentum relative to sector peers.
Is ACB or JNJ more attractively valued?
Johnson & Johnson (JNJ) scores higher on Valuation (7.3/10 vs 3.8/10). Valuation is assessed using P/E ratio, analyst price targets, and 52-week range positioning relative to sector peers.
What do analysts say about ACB vs JNJ?
There are ACB with a consensus price target of N/A, and 23 analysts covering JNJ with a consensus target of $252.87. Analyst consensus ratings are aggregated from Wall Street research and do not constitute investment advice.
Which is more profitable: ACB or JNJ?
Johnson & Johnson (JNJ) scores higher on Quality (9.3/10 vs 2.1/10). Net profit margin: ACB at -42.4%, JNJ at 21.8%. Quality scores reflect profit margins, return on equity, and free cash flow generation.
Which has stronger financial health: ACB or JNJ?
Aurora Cannabis Inc. (ACB) scores higher on Financial Health (7.7/10 vs 6.5/10). Market beta: ACB at 1.34, JNJ at 0.26. Health scores consider beta, debt-to-equity, and current ratio. All investments carry risk — this is not investment advice.
What are the market caps of ACB and JNJ?
Aurora Cannabis Inc. (ACB) has a market capitalisation of $181M, while Johnson & Johnson (JNJ) has a market cap of $549.8B. Market cap data is sourced from Yahoo Finance and reflects the most recent available figures.
Do ACB or JNJ pay dividends?
ACB does not currently pay a dividend, while JNJ pays a dividend yield of 2.35%. Dividend yields fluctuate with share price and company payout decisions.
Related Comparisons
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →